{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T17:47:03Z","timestamp":1787939223413,"version":"build-2784847793"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s11102-025-01545-w","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T17:06:56Z","timestamp":1751389616000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Endoscopic endonasal transcavernous surgery for a contemporary series of 59 prolactinomas"],"prefix":"10.1007","volume":"28","author":[{"given":"Taishi","family":"Nakase","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir A.","family":"Ljubimov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia J.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannes","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Vigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Katznelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Fernandez-Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"1545_CR1","doi-asserted-by":"publisher","first-page":"101290","DOI":"10.1016\/j.beem.2019.101290","volume":"33","author":"P Chanson","year":"2019","unstructured":"Chanson P, Maiter D (2019) The epidemiology, diagnosis and treatment of prolactinomas: the old and the new. Best Pract Res Clin Endocrinol Metab 33:101290. https:\/\/doi.org\/10.1016\/j.beem.2019.101290","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"1545_CR2","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/s41574-023-00886-5","volume":"19","author":"S Petersenn","year":"2023","unstructured":"Petersenn S, Fleseriu M, Casanueva FF et al (2023) Diagnosis and management of prolactin-secreting pituitary adenomas: a pituitary society international consensus statement. Nat Rev Endocrinol 19:722\u2013740. https:\/\/doi.org\/10.1038\/s41574-023-00886-5","journal-title":"Nat Rev Endocrinol"},{"key":"1545_CR3","doi-asserted-by":"publisher","first-page":"3053","DOI":"10.1210\/jcem.85.9.6798","volume":"85","author":"JJ Pinzone","year":"2000","unstructured":"Pinzone JJ, Katznelson L, Danila DC et al (2000) Primary medical therapy of Micro- and macroprolactinomas in men**. J Clin Endocrinol Metabolism 85:3053\u20133057. https:\/\/doi.org\/10.1210\/jcem.85.9.6798","journal-title":"J Clin Endocrinol Metabolism"},{"key":"1545_CR4","doi-asserted-by":"publisher","first-page":"R31","DOI":"10.1530\/EO-21-0038","volume":"2","author":"SMC De Sousa","year":"2022","unstructured":"De Sousa SMC (2022) Dopamine agonist therapy for prolactinomas: do we need to rethink the place of surgery in prolactinoma management? Endocr Oncol 2:R31\u2013R50. https:\/\/doi.org\/10.1530\/EO-21-0038","journal-title":"Endocr Oncol"},{"key":"1545_CR5","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1210\/er.2005-9998","volume":"27","author":"MP Gillam","year":"2006","unstructured":"Gillam MP, Molitch ME, Lombardi G, Colao A (2006) Advances in the treatment of prolactinomas. Endocr Rev 27:485\u2013534. https:\/\/doi.org\/10.1210\/er.2005-9998","journal-title":"Endocr Rev"},{"key":"1545_CR6","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1210\/jcem.84.7.5810","volume":"84","author":"J Verhelst","year":"1999","unstructured":"Verhelst J, Abs R, Maiter D et al (1999) Cabergoline in the treatment of hyperprolactinemia: A study in 455 patients. J Clin Endocrinol Metabolism 84:2518\u20132522. https:\/\/doi.org\/10.1210\/jcem.84.7.5810","journal-title":"J Clin Endocrinol Metabolism"},{"key":"1545_CR7","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s12020-015-0727-2","volume":"51","author":"S Noronha","year":"2016","unstructured":"Noronha S, Stokes V, Karavitaki N, Grossman A (2016) Treating prolactinomas with dopamine agonists: always worth the gamble? Endocrine 51:205\u2013210. https:\/\/doi.org\/10.1007\/s12020-015-0727-2","journal-title":"Endocrine"},{"key":"1545_CR8","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1210\/clinem\/dgz076","volume":"105","author":"SMC De Sousa","year":"2020","unstructured":"De Sousa SMC, Baranoff J, Rushworth RL et al (2020) Impulse control disorders in dopamine Agonist-Treated hyperprolactinemia: prevalence and risk factors. J Clin Endocrinol Metabolism 105:e108\u2013e118. https:\/\/doi.org\/10.1210\/clinem\/dgz076","journal-title":"J Clin Endocrinol Metabolism"},{"key":"1545_CR9","doi-asserted-by":"publisher","first-page":"e32","DOI":"10.1210\/clinem\/dgz144","volume":"105","author":"AH Zamanipoor Najafabadi","year":"2020","unstructured":"Zamanipoor Najafabadi AH, Zandbergen IM, de Vries F et al (2020) Surgery as a viable alternative First-Line treatment for prolactinoma patients. A systematic review and Meta-Analysis. J Clin Endocrinol Metab 105:e32\u201341. https:\/\/doi.org\/10.1210\/clinem\/dgz144","journal-title":"J Clin Endocrinol Metab"},{"key":"1545_CR10","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1007\/s11102-014-0617-2","volume":"18","author":"J Hu","year":"2015","unstructured":"Hu J, Zheng X, Zhang W, Yang H (2015) Current drug withdrawal strategy in prolactinoma patients treated with cabergoline: a systematic review and meta-analysis. Pituitary 18:745\u2013751. https:\/\/doi.org\/10.1007\/s11102-014-0617-2","journal-title":"Pituitary"},{"key":"1545_CR11","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1210\/jc.2010-1692","volume":"96","author":"S Melmed","year":"2011","unstructured":"Melmed S, Casanueva FF, Hoffman AR et al (2011) Diagnosis and treatment of hyperprolactinemia: an endocrine society clinical practice guideline. J Clin Endocrinol Metabolism 96:273\u2013288. https:\/\/doi.org\/10.1210\/jc.2010-1692","journal-title":"J Clin Endocrinol Metabolism"},{"key":"1545_CR12","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.nec.2019.05.010","volume":"30","author":"DA Donoho","year":"2019","unstructured":"Donoho DA, Laws ER (2019) The role of surgery in the management of prolactinomas. Neurosurg Clin North Am 30:509\u2013514. https:\/\/doi.org\/10.1016\/j.nec.2019.05.010","journal-title":"Neurosurg Clin North Am"},{"key":"1545_CR13","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1530\/EJE-21-0293","volume":"185","author":"B Baussart","year":"2021","unstructured":"Baussart B, Villa C, Jouinot A et al (2021) Pituitary surgery as alternative to dopamine agonists treatment for microprolactinomas: a cohort study. Eur J Endocrinol 185:783\u2013791. https:\/\/doi.org\/10.1530\/EJE-21-0293","journal-title":"Eur J Endocrinol"},{"key":"1545_CR14","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s12020-016-1115-2","volume":"55","author":"L Andereggen","year":"2017","unstructured":"Andereggen L, Frey J, Andres RH et al (2017) 10-year follow-up study comparing primary medical vs. surgical therapy in women with prolactinomas. Endocrine 55:223\u2013230. https:\/\/doi.org\/10.1007\/s12020-016-1115-2","journal-title":"Endocrine"},{"key":"1545_CR15","doi-asserted-by":"publisher","first-page":"430","DOI":"10.3171\/2017.2.JNS162214","volume":"129","author":"JC Fernandez-Miranda","year":"2018","unstructured":"Fernandez-Miranda JC, Zwagerman NT, Abhinav K et al (2018) Cavernous sinus compartments from the endoscopic endonasal approach: anatomical considerations and surgical relevance to adenoma surgery. J Neurosurg 129:430\u2013441. https:\/\/doi.org\/10.3171\/2017.2.JNS162214","journal-title":"J Neurosurg"},{"key":"1545_CR16","doi-asserted-by":"publisher","first-page":"9919","DOI":"10.1038\/s41598-022-12980-1","volume":"12","author":"A Mohyeldin","year":"2022","unstructured":"Mohyeldin A, Katznelson LJ, Hoffman AR et al (2022) Prospective intraoperative and histologic evaluation of cavernous sinus medial wall invasion by pituitary adenomas and its implications for acromegaly remission outcomes. Sci Rep 12:9919. https:\/\/doi.org\/10.1038\/s41598-022-12980-1","journal-title":"Sci Rep"},{"key":"1545_CR17","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3171\/2018.3.JNS18596","volume":"131","author":"HQ Truong","year":"2019","unstructured":"Truong HQ, Lieber S, Najera E et al (2019) The medial wall of the cavernous sinus. Part 1: surgical anatomy, ligaments, and surgical technique for its mobilization and\/or resection. J Neurosurg 131:122\u2013130. https:\/\/doi.org\/10.3171\/2018.3.JNS18596","journal-title":"J Neurosurg"},{"key":"1545_CR18","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3171\/2018.5.JNS18595","volume":"131","author":"S Cohen-Cohen","year":"2019","unstructured":"Cohen-Cohen S, Gardner PA, Alves-Belo JT et al (2019) The medial wall of the cavernous sinus. Part 2: selective medial wall resection in 50 pituitary adenoma patients. J Neurosurg 131:131\u2013140. https:\/\/doi.org\/10.3171\/2018.5.JNS18595","journal-title":"J Neurosurg"},{"key":"1545_CR19","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.3171\/2021.12.JNS211974","volume":"137","author":"Y Xu","year":"2022","unstructured":"Xu Y, Nunez MA, Vigo V et al (2022) Microsurgical anatomy of the dorsal clinoidal space: implications for endoscopic endonasal parasellar surgery. J Neurosurg 137:1418\u20131430. https:\/\/doi.org\/10.3171\/2021.12.JNS211974","journal-title":"J Neurosurg"},{"key":"1545_CR20","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1159\/000495775","volume":"109","author":"D Maiter","year":"2019","unstructured":"Maiter D (2019) Management of dopamine Agonist-Resistant prolactinoma. Neuroendocrinology 109:42\u201350. https:\/\/doi.org\/10.1159\/000495775","journal-title":"Neuroendocrinology"},{"key":"1545_CR21","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/s41574-024-00976-y","volume":"20","author":"SMC De Sousa","year":"2024","unstructured":"De Sousa SMC, Jukes AK, Candy NG et al (2024) Tumour fibrosis in dopamine agonist-exposed prolactinomas is a diminishing concern. Nat Rev Endocrinol 20:314\u2013314. https:\/\/doi.org\/10.1038\/s41574-024-00976-y","journal-title":"Nat Rev Endocrinol"},{"key":"1545_CR22","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s11102-005-5085-2","volume":"8","author":"ME Molitch","year":"2005","unstructured":"Molitch ME (2005) Pharmacologic resistance in prolactinoma patients. Pituitary 8:43\u201352. https:\/\/doi.org\/10.1007\/s11102-005-5085-2","journal-title":"Pituitary"},{"key":"1545_CR23","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s11060-013-1270-8","volume":"117","author":"ME Molitch","year":"2014","unstructured":"Molitch ME (2014) Management of medically refractory prolactinoma. J Neurooncol 117:421\u2013428. https:\/\/doi.org\/10.1007\/s11060-013-1270-8","journal-title":"J Neurooncol"},{"key":"1545_CR24","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s11102-013-0502-4","volume":"17","author":"A Paluzzi","year":"2014","unstructured":"Paluzzi A, Fernandez-Miranda JC, Tonya Stefko S et al (2014) Endoscopic endonasal approach for pituitary adenomas: a series of 555 patients. Pituitary 17:307\u2013319. https:\/\/doi.org\/10.1007\/s11102-013-0502-4","journal-title":"Pituitary"},{"key":"1545_CR25","doi-asserted-by":"crossref","unstructured":"Constanzo F, Rychen J, Lee CK et al (2025) Patterns of invasion of the medial wall of the cavernous sinus by Pituitary Adenomas. Journal of Neurosurgery In press","DOI":"10.3171\/2025.3.JNS242823"},{"key":"1545_CR26","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s11102-009-0195-x","volume":"13","author":"JA Gondim","year":"2010","unstructured":"Gondim JA, Schops M, De Almeida JPC et al (2010) Endoscopic endonasal transsphenoidal surgery: surgical results of 228 pituitary adenomas treated in a pituitary center. Pituitary 13:68\u201377. https:\/\/doi.org\/10.1007\/s11102-009-0195-x","journal-title":"Pituitary"},{"key":"1545_CR27","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgae652","author":"VR Van Trigt","year":"2024","unstructured":"Van Trigt VR, Bakker LEH, Pelsma ICM et al (2024) The changing treatment paradigm for Prolactinoma\u2014A prospective series of 100 consecutive neurosurgical cases. J Clin Endocrinol Metabolism. https:\/\/doi.org\/10.1210\/clinem\/dgae652. dgae652","journal-title":"J Clin Endocrinol Metabolism"},{"key":"1545_CR28","doi-asserted-by":"publisher","first-page":"e858","DOI":"10.1016\/j.wneu.2022.12.003","volume":"170","author":"A Uzuner","year":"2023","unstructured":"Uzuner A, Yilmaz E, Caklili M et al (2023) Endoscopic transnasal approach for microprolactinomas with experience of 105 cases in a single center: paradigmal shift for conventional medical therapy. World Neurosurg 170:e858\u2013e867. https:\/\/doi.org\/10.1016\/j.wneu.2022.12.003","journal-title":"World Neurosurg"},{"key":"1545_CR29","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1007\/s12020-018-1652-y","volume":"62","author":"N Yi","year":"2018","unstructured":"Yi N, Ji L, Zhang Q et al (2018) Long-term follow-up of female prolactinoma patients at child-bearing age after transsphenoidal surgery. Endocrine 62:76\u201382. https:\/\/doi.org\/10.1007\/s12020-018-1652-y","journal-title":"Endocrine"},{"key":"1545_CR30","doi-asserted-by":"publisher","first-page":"102919","DOI":"10.1016\/j.arcmed.2023.102919","volume":"54","author":"IM Zandbergen","year":"2023","unstructured":"Zandbergen IM, Huntoon KM, White TG et al (2023) Efficacy and safety of endoscopic transsphenoidal resection for prolactinoma: A retrospective multicenter Case-series. Arch Med Res 54:102919. https:\/\/doi.org\/10.1016\/j.arcmed.2023.102919","journal-title":"Arch Med Res"},{"key":"1545_CR31","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1530\/EJE-11-1000","volume":"166","author":"V Primeau","year":"2012","unstructured":"Primeau V, Raftopoulos C, Maiter D (2012) Outcomes of transsphenoidal surgery in prolactinomas: improvement of hormonal control in dopamine agonist-resistant patients. Eur J Endocrinol 166:779\u2013786. https:\/\/doi.org\/10.1530\/EJE-11-1000","journal-title":"Eur J Endocrinol"},{"key":"1545_CR32","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1055\/a-1247-4908","volume":"129","author":"S Giese","year":"2021","unstructured":"Giese S, Nasi-Kordhishti I, Honegger J (2021) Outcomes of transsphenoidal microsurgery for Prolactinomas\u2013 A contemporary series of 162 cases. Exp Clin Endocrinol Diabetes 129:163\u2013171. https:\/\/doi.org\/10.1055\/a-1247-4908","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"1545_CR33","doi-asserted-by":"publisher","first-page":"307","DOI":"10.3171\/jns.2002.97.2.0307","volume":"97","author":"AP Amar","year":"2002","unstructured":"Amar AP, Couldwell WT, Chen JCT, Weiss MH (2002) Predictive value of serum prolactin levels measured immediately after transsphenoidal surgery. J Neurosurg 97:307\u2013314. https:\/\/doi.org\/10.3171\/jns.2002.97.2.0307","journal-title":"J Neurosurg"},{"key":"1545_CR34","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1007\/s11102-021-01168-x","volume":"24","author":"JY Park","year":"2021","unstructured":"Park JY, Choi W, Hong AR et al (2021) Surgery is a safe, effective first-line treatment modality for noninvasive prolactinomas. Pituitary 24:955\u2013963. https:\/\/doi.org\/10.1007\/s11102-021-01168-x","journal-title":"Pituitary"},{"key":"1545_CR35","doi-asserted-by":"publisher","first-page":"R213","DOI":"10.1530\/EJE-14-0013","volume":"170","author":"D Maiter","year":"2014","unstructured":"Maiter D, Delgrange E (2014) THERAPY OF ENDOCRINE DISEASE: the challenges in managing giant prolactinomas. Eur J Endocrinol 170:R213\u2013R227. https:\/\/doi.org\/10.1530\/EJE-14-0013","journal-title":"Eur J Endocrinol"},{"key":"1545_CR36","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/cen.12242","volume":"79","author":"AB Moraes","year":"2013","unstructured":"Moraes AB, Silva CM, dos Vieira Neto S, Gadelha L MR (2013) Giant prolactinomas: the therapeutic approach. Clin Endocrinol (Oxf) 79:447\u2013456. https:\/\/doi.org\/10.1111\/cen.12242","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1545_CR37","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.ecl.2020.04.002","volume":"49","author":"AF Daly","year":"2020","unstructured":"Daly AF, Beckers A (2020) The epidemiology of pituitary adenomas. Endocrinol Metab Clin North Am 49:347\u2013355. https:\/\/doi.org\/10.1016\/j.ecl.2020.04.002","journal-title":"Endocrinol Metab Clin North Am"},{"key":"1545_CR38","doi-asserted-by":"publisher","first-page":"4709","DOI":"10.1210\/jc.2003-030461","volume":"88","author":"FG Barker","year":"2003","unstructured":"Barker FG, Klibanski A, Swearingen B (2003) Transsphenoidal surgery for pituitary tumors in the united states, 1996\u20132000: mortality, morbidity, and the effects of hospital and surgeon volume. J Clin Endocrinol Metabolism 88:4709\u20134719. https:\/\/doi.org\/10.1210\/jc.2003-030461","journal-title":"J Clin Endocrinol Metabolism"},{"key":"1545_CR39","doi-asserted-by":"publisher","first-page":"803","DOI":"10.3171\/2014.12.JNS141083","volume":"122","author":"ASG Micko","year":"2015","unstructured":"Micko ASG, W\u00f6hrer A, Wolfsberger S, Knosp E (2015) Invasion of the cavernous sinus space in pituitary adenomas: endoscopic verification and its correlation with an MRI-based classification. JNS 122:803\u2013811. https:\/\/doi.org\/10.3171\/2014.12.JNS141083","journal-title":"JNS"},{"key":"1545_CR40","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s11102-007-0072-4","volume":"11","author":"ZB Wu","year":"2008","unstructured":"Wu ZB, Su ZP, Wu JS et al (2008) Five years follow-up of invasive prolactinomas with special reference to the control of cavernous sinus invasion. Pituitary 11:63\u201370. https:\/\/doi.org\/10.1007\/s11102-007-0072-4","journal-title":"Pituitary"},{"key":"1545_CR41","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1227\/01.NEU.0000126953.59406.77","volume":"55","author":"A Yasuda","year":"2004","unstructured":"Yasuda A, Campero A, Martins C et al (2004) The medial wall of the cavernous sinus: microsurgical anatomy. Neurosurgery 55:179\u2013190. https:\/\/doi.org\/10.1227\/01.NEU.0000126953.59406.77","journal-title":"Neurosurgery"},{"key":"1545_CR42","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.3171\/jns.2002.97.6.1343","volume":"97","author":"RD Dickerman","year":"2002","unstructured":"Dickerman RD, Oldfield EH (2002) Basis of persistent and recurrent Cushing disease: an analysis of findings at repeated pituitary surgery. J Neurosurg 97:1343\u20131349. https:\/\/doi.org\/10.3171\/jns.2002.97.6.1343","journal-title":"J Neurosurg"},{"key":"1545_CR43","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1227\/00006123-199310000-00008","volume":"33","author":"E Knosp","year":"1993","unstructured":"Knosp E, Steiner E, Kitz K, Matula C (1993) Pituitary adenomas with invasion of the cavernous sinus space: A magnetic resonance imaging classification compared with surgical findings. Neurosurgery 33:610\u2013618. https:\/\/doi.org\/10.1227\/00006123-199310000-00008","journal-title":"Neurosurgery"},{"key":"1545_CR44","doi-asserted-by":"publisher","first-page":"S375","DOI":"10.1097\/00006123-200210001-00010","volume":"51","author":"AL Rhoton","year":"2002","unstructured":"Rhoton AL (2002) The cavernous sinus, the cavernous venous plexus, and the carotid collar. Neurosurgery 51:S375\u2013410","journal-title":"Neurosurgery"},{"key":"1545_CR45","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.3171\/2023.3.JNS221949","volume":"139","author":"K Asmaro","year":"2023","unstructured":"Asmaro K, Zhang M, Rodrigues AJ et al (2023) Cytodifferentiation of pituitary tumors influences pathogenesis and cavernous sinus invasion. J Neurosurg 139:1216\u20131224. https:\/\/doi.org\/10.3171\/2023.3.JNS221949","journal-title":"J Neurosurg"},{"key":"1545_CR46","doi-asserted-by":"publisher","first-page":"717","DOI":"10.3171\/2019.4.JNS183443","volume":"133","author":"Y-C Hung","year":"2020","unstructured":"Hung Y-C, Lee C-C, Yang H et al (2020) The benefit and risk of stereotactic radiosurgery for prolactinomas: an international multicenter cohort study. J Neurosurg 133:717\u2013726. https:\/\/doi.org\/10.3171\/2019.4.JNS183443","journal-title":"J Neurosurg"},{"key":"1545_CR47","doi-asserted-by":"publisher","first-page":"4998","DOI":"10.3390\/cancers13194998","volume":"13","author":"L Albano","year":"2021","unstructured":"Albano L, Losa M, Barzaghi LR et al (2021) Gamma knife radiosurgery for pituitary tumors: A systematic review and Meta-Analysis. Cancers 13:4998. https:\/\/doi.org\/10.3390\/cancers13194998","journal-title":"Cancers"},{"key":"1545_CR48","doi-asserted-by":"publisher","first-page":"70","DOI":"10.4158\/EP13165.RA","volume":"20","author":"R Carija","year":"2014","unstructured":"Carija R, Tudor M, Vucina D (2014) Effect of the preoperative use of dopamine agonists in the postoperative course of prolactinomas: A systematic review. Endocr Pract 20:70\u201374. https:\/\/doi.org\/10.4158\/EP13165.RA","journal-title":"Endocr Pract"},{"key":"1545_CR49","doi-asserted-by":"publisher","first-page":"e349","DOI":"10.1016\/j.wneu.2021.07.035","volume":"154","author":"K Wright","year":"2021","unstructured":"Wright K, Chaker L, Pacione D et al (2021) Determinants of surgical remission in prolactinomas: A systematic review and Meta-Analysis. World Neurosurg 154:e349\u2013e369. https:\/\/doi.org\/10.1016\/j.wneu.2021.07.035","journal-title":"World Neurosurg"},{"key":"1545_CR50","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1007\/s11102-008-0135-1","volume":"12","author":"ME Sughrue","year":"2009","unstructured":"Sughrue ME, Chang EF, Tyrell JB et al (2009) Pre-operative dopamine agonist therapy improves post-operative tumor control following prolactinoma resection. Pituitary 12:158\u2013164. https:\/\/doi.org\/10.1007\/s11102-008-0135-1","journal-title":"Pituitary"},{"key":"1545_CR51","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1210\/clinem\/dgad758","volume":"109","author":"Z Chen","year":"2024","unstructured":"Chen Z, Shou X, Ji L et al (2024) Presurgical medical treatment in prolactinomas: surgical implications and pathological characteristics from 290 cases. J Clin Endocrinol Metabolism 109:1433\u20131442. https:\/\/doi.org\/10.1210\/clinem\/dgad758","journal-title":"J Clin Endocrinol Metabolism"},{"key":"1545_CR52","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1046\/j.1365-2265.1996.738559.x","volume":"44","author":"SG Soule","year":"1996","unstructured":"Soule SG, Farhi J, Conway GS et al (1996) The outcome of hypophysectomy for prolactinomas in the era of dopamine agonist therapy. Clin Endocrinol 44:711\u2013716. https:\/\/doi.org\/10.1046\/j.1365-2265.1996.738559.x","journal-title":"Clin Endocrinol"},{"key":"1545_CR53","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1007\/s11102-021-01188-7","volume":"24","author":"KJ Yagnik","year":"2021","unstructured":"Yagnik KJ, Erickson D, Bancos I et al (2021) Surgical outcomes of medically failed prolactinomas: a systematic review and meta-analysis. Pituitary 24:978\u2013988. https:\/\/doi.org\/10.1007\/s11102-021-01188-7","journal-title":"Pituitary"},{"key":"1545_CR54","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1210\/jcem-63-2-383","volume":"63","author":"MM Esiri","year":"1986","unstructured":"Esiri MM, Bevan JS, Burke CW, Adams CBT (1986) Effect of Bromocriptine treatment on the fibrous tissue content of Prolactin-Secreting and nonfunctioning macroadenomas of the pituitary gland. J Clin Endocrinol Metabolism 63:383\u2013388. https:\/\/doi.org\/10.1210\/jcem-63-2-383","journal-title":"J Clin Endocrinol Metabolism"},{"key":"1545_CR55","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s11102-010-0261-4","volume":"14","author":"M Menucci","year":"2011","unstructured":"Menucci M, Qui\u00f1ones-Hinojosa A, Burger P, Salvatori R (2011) Effect of dopaminergic drug treatment on surgical findings in prolactinomas. Pituitary 14:68\u201374. https:\/\/doi.org\/10.1007\/s11102-010-0261-4","journal-title":"Pituitary"},{"key":"1545_CR56","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1210\/jcem-58-6-1179","volume":"58","author":"AM Landolt","year":"1984","unstructured":"Landolt AM, Osterwalder V (1984) Perivascular fibrosis in prolactinomas: is it increased by bromocriptine**. J Clin Endocrinol Metabolism 58:1179\u20131183. https:\/\/doi.org\/10.1210\/jcem-58-6-1179","journal-title":"J Clin Endocrinol Metabolism"},{"key":"1545_CR57","doi-asserted-by":"publisher","first-page":"e66","DOI":"10.1055\/s-0044-1786740","volume":"85","author":"IL Pecorari","year":"2024","unstructured":"Pecorari IL, Qama E, Akbar N et al (2024) The effect of preoperative Cabergoline on prolactinoma fibrosis: A case series. J Neurol Surg Rep 85:e66\u2013e73. https:\/\/doi.org\/10.1055\/s-0044-1786740","journal-title":"J Neurol Surg Rep"},{"key":"1545_CR58","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1186\/s13063-021-05604-y","volume":"22","author":"IM Zandbergen","year":"2021","unstructured":"Zandbergen IM, Zamanipoor Najafabadi AH, Pelsma ICM et al (2021) The prolact studies \u2014 a study protocol for a combined randomised clinical trial and observational cohort study design in prolactinoma. Trials 22:653. https:\/\/doi.org\/10.1186\/s13063-021-05604-y","journal-title":"Trials"},{"key":"1545_CR59","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s11102-011-0347-7","volume":"15","author":"F Roelfsema","year":"2012","unstructured":"Roelfsema F, Biermasz NR, Pereira AM (2012) Clinical factors involved in the recurrence of pituitary adenomas after surgical remission: a structured review and meta-analysis. Pituitary 15:71\u201383. https:\/\/doi.org\/10.1007\/s11102-011-0347-7","journal-title":"Pituitary"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-025-01545-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-025-01545-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-025-01545-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T00:19:53Z","timestamp":1757204393000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11102-025-01545-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":59,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["1545"],"URL":"https:\/\/doi.org\/10.1007\/s11102-025-01545-w","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"30 May 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and relevant ethical review board approval was obtained from the Institutional Review Board of Stanford University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All patients were evaluated and treated with informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Author L.K. is a member of the editorial board of Pituitary. The other authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"81"}}